- About Us
- Advisory Board
- Editorial
- Contact Us
- Advertise
- Contact MJH LS
- Do Not Sell My Information
- Terms and Conditions
- Privacy
© 2022 MJH Life Sciences™ , NeurologyLive – Clinical Neurology News and Neurology Expert Insights. All rights reserved.
Epilepsy
The NeurologyLive® epilepsy clinical focus page provides information, podcasts, videos, and news about the latest FDA actions, clinical guideline updates, study and clinical trial findings, and interviews with physicians related to epilepsy and related epileptic conditions, including Lennox-Gastaut syndrome, Dravet syndrome, tuberous sclerosis complex, focal seizures, nonmotor seizures, and more.
Check out some of NeurologyLive®'s featured content in the carousel below.
Although Increased, Risk of Epilepsy and Seizures Following COVID-19 Remain Low
November 28, 2022
Article
The relative risk of epilepsy or seizures after COVID-19 infection, compared with influenza infection, was more marked amongst children and non-hospitalized individuals over the 6-month time horizon.
Expanding Neuropalliative Care to New Disease States: Benzi Kluger, MD, MS
November 28, 2022
Video
The president of the International Neuropalliative Care Society detailed potential disease states that could benefit from neuropalliative care as well as the importance of the patient community in expanding this type of approach. [WATCH TIME: 4 minutes]
This Week on NeurologyLive® — November 28, 2022
November 28, 2022
Article
Here's some of what is coming soon to NeurologyLive® this week.
NeurologyLive® Brain Games: November 27, 2022
November 27, 2022
Article
Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is sleep disorders.
NeurologyLive® Friday 5 — November 25, 2022
November 25, 2022
Article
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending November 25, 2022.
Cell Therapy NRTX-1001 Shows Significant Effect on Drug-Resistant Epilepsy in Early Data
November 22, 2022
Article
NRTX-1001, an injectable suspension of high-purity inhibitory neurons, is currently being assessed in a phase 1/2 trial that includes a dose-escalation period comprising of 10 individuals with mesial temporal lobe epilepsy.
This Week on NeurologyLive® — November 21, 2022
November 21, 2022
Article
Here's some of what is coming soon to NeurologyLive® this week.
NeurologyLive® Brain Games: November 20, 2022
November 20, 2022
Article
Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is neuromuscular disorders.
Positive Results of STK-001 in Dravet, Zavegepant Meets Primary End Points, FDA Accepts NDA of Zilucoplan for Myasthenia Gravis
November 19, 2022
Video
Neurology News Network for the week ending November 19, 2022. [WATCH TIME: 3 minutes]
NeurologyLive® Friday 5 — November 18, 2022
November 18, 2022
Article
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending November 18, 2022.
Latest News
NeuroVoices: Carrie Hersh, DO, MSc, on Applying 2-Stage Models to Improve Disease-Modifying Therapy Selection in MS
Lecanemab Represents Promising Therapy for Alzheimer Disease, Posts Positive Phase 3 Secondary Analyses
Digital Treatment Approach May Help Reduce Healthcare Burden for MS Fatigue: Federica Picariello, PhD
CGRP Antagonist Atogepant Improves Patient-Reported Outcomes as Migraine Preventive